Informações:
Falhas:
ID
33732
Descrição
A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01981031
Link
https://clinicaltrials.gov/show/NCT01981031
Palavras-chave
Versões (1)
- 21/12/2018 21/12/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
21 de dezembro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes NCT01981031
Eligibility Diabetes NCT01981031
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes NCT01981031
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Insulin-Dependent Diabetes Mellitus Disease length
Item
type 1 diabetes mellitus for at least (or equal to ) 12 months,
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Insulin injection Multiple Daily | Insulin pump Treatment
Item
treated with multiple daily insulin injections or insulin pump treatment for at least (or equal to) 12 months,
boolean
C0199782 (UMLS CUI [1,1])
C0439064 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C1140609 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0439064 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C1140609 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Body mass index
Item
body mass index (bmi): 18.0-28.0kg/m2 (both inclusive)
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes mellitus,
boolean
C0011860 (UMLS CUI [1])
Investigational New Drugs
Item
the receipt of any investigational product within 3 month prior to first dosing,
boolean
C0013230 (UMLS CUI [1])
Abnormality Clinical Significance
Item
clinically significant abnormalities, as judged by the investigator,
boolean
C1704258 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Systemic therapy | Pharmaceutical Preparations Interfere with Glucose metabolism
Item
any systemic treatment with drugs known to interfere with glucose metabolism,
boolean
C1515119 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0596620 (UMLS CUI [2,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0596620 (UMLS CUI [2,3])
Alcoholic Intoxication, Chronic | Drug and chemical abuse | Tobacco use
Item
history of alcoholism or drug/chemical abuse and any tobacco product within 5 years prior to screening
boolean
C0001973 (UMLS CUI [1])
C0851847 (UMLS CUI [2])
C0543414 (UMLS CUI [3])
C0851847 (UMLS CUI [2])
C0543414 (UMLS CUI [3])
Blood Donation | Plasma Donation | Blood Donation Amount | Plasma Donation Amount
Item
blood or plasma donation in the past month or more than 500ml within 3 months prior to screening
boolean
C0005794 (UMLS CUI [1])
C0032105 (UMLS CUI [2,1])
C0005794 (UMLS CUI [2,2])
C0005794 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0032105 (UMLS CUI [4,1])
C0005794 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
C0032105 (UMLS CUI [2,1])
C0005794 (UMLS CUI [2,2])
C0005794 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0032105 (UMLS CUI [4,1])
C0005794 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])